非标准化植物制品对细胞色素P450的抑制活性研究
研究采用HPLC和LC-MS/MS分析R-tab、H-tab和E-cap三种植物制品,并通过体外实验检测其对CYP1A2、CYP2D6和CYP3A4的诱导与抑制活性。结果显示三者均无显著诱导作用,但R-tab和H-tab可抑制CYP3A4 mRNA和酶活性,提示需关注草药-药物相互作用风险。
要点
- R-tab和H-tab对CYP3A4 mRNA及酶活性有中度抑制作用。
- E-cap抑制CYP1A2代谢活性,IC50为37.24 μg/mL。
- 三种制品对CYP1A2、CYP2D6和CYP3A4均无显著诱导作用。
核心结论
- R-tab和H-tab对CYP3A4 mRNA和酶活性有中度抑制作用,提示存在草药-药物相互作用风险。
研究设计与样本
- 体外研究,使用R-tab、H-tab和E-cap的甲醇提取物,通过HPLC和LC-MS/MS分析,并采用多重RT-qPCR、P450-Glo™活性测定和LC-MS/MS法检测CYP1A2、CYP2D6和CYP3A4的诱导与抑制活性。
主要发现
- 三种植物制品均未显著诱导CYP1A2、CYP2D6和CYP3A4的mRNA表达。
- R-tab从0.01 μg/mL起显著抑制CYP1A2 mRNA表达。
- H-tab从0.1 μg/mL起抑制CYP1A2和CYP3A4 mRNA表达。
- E-cap抑制CYP1A2代谢活性,IC50为37.24 μg/mL。
- R-tab、H-tab和E-cap抑制CYP3A4酶活性,IC50分别为17.42、18.20和20.60 μg/mL。
关键数值与推荐
- E-cap对CYP1A2代谢活性的IC50为37.24 μg/mL。
- R-tab、H-tab和E-cap对CYP3A4酶活性的IC50分别为17.42、18.20和20.60 μg/mL。
- LC-MS/MS法中R-tab和H-tab对睾酮代谢的IC50分别为51.90和56.90 μg/mL。
临床怎么用
- 临床使用R-tab和H-tab时需警惕与CYP3A4底物药物的相互作用。
- 体外实验可为植物制品的安全标签提供最低限度数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: R-tab, H-tab and E-cap botanical products are used for the treatment of various ailments. R-tab is traditionally prescribed for improving urination, H-tab is for relieving piles, hemorrhoids, fissures, and rectal inflammation and E-cap is for regulating menstruation. AIMS OF THE STUDY: To extract the botanical products and determine their potential interaction with the cytochrome P450 (CYP1A2, CYP2D6 and CYP3A4) enzymes. MATERIALS AND METHODS: R-tab, H-tab and E-cap botanical products were first extracted using solvents and analyzed using HPLC and LC-MS/MS. The effects of methanol extracts on the cytochrome induction and inhibition activities were determined using a series of in vitro assays, including multiplex RT-qPCR, CYP activity assays (P450-Glo™) and LC-MS/MS-based assays. For the CYP induction assay, omeprazole, rifampicin and dexamethasone were used as CYP1A2, CYP2D6 and CYP3A4 inducers, respectively. Ketoconazole and acetaminophen were used as positive and negative controls for the CYP3A4 inhibition assay, whereas furafylline and ketoconazole were used as positive and negative controls for the CYP1A2 inhibition assay. RESULTS: All three botanical products did not show any significant induction in CYP1A2, CYP2D6 and CYP3A4 mRNA expression. By contrast, R-tab inhibited the mRNA expression of CYP1A2 significantly from the lowest concentration of 0.01 μg/mL, while, H-tab inhibited the mRNA expression of CYP1A2 and CYP3A4 from 0.1 μg/mL. Based on the P450 Glo assays, E-cap extract inhibited the metabolic activity of CYP1A2 with an IC50 value of 37.24 μg/mL. On the other hand, R-tab, H-tab and E-cap showed inhibitory effects on the CYP3A4 enzymatic activity with IC50 values of 17.42, 18.20 and 20.60 μg/mL, respectively. However, using the LC-MS/MS-based methods, the concentration-dependent effects of R-tab and H-tab extracts on the metabolism of testosterone appeared to be more prominent, with IC50 values of 51.90 and 56.90 μg/mL as compared with the rest of the results, which were all above 100 μg/mL CONCLUSION: The CYP3A4 mRNA and enzymatic activity were moderately inhibited by R-tab and H-tab. Methanol extract of botanical products in solid dosage forms can be evaluated for their herb-drug interaction risks using in vitro assays and may provide the minimum data required for safety labeling.
引用
- Abduraman MA, Mustafa NH, Yaacob NS, et al. Cytochrome P450 inhibition activities of non-standardized botanical products. J Ethnopharmacol. 2022. PMID: 35659627. doi:10.1016/j.jep.2022.115406
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。